- Tytuł:
- Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
- Autorzy:
- Źródło:
- In The Lancet Infectious Diseases June 2016 16(6):685-697
Czasopismo naukowe